Account
Inquiry
Tirzepatide 10mg is a high-purity peptide compound with dual agonist activity at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This pharmaceutical grade white powder has shown significant potential in clinical research for type 2 diabetes treatment and weight management applications.
The molecular structure of tirzepatide 10mg features a PEG-modified lysine side chain that enhances water solubility while maintaining biological activity. This modification contributes to the compound's extended half-life and improved pharmacokinetic profile compared to native peptides.
Clinical studies have demonstrated tirzepatide's superior efficacy in both glycemic control and weight reduction compared to selective GLP-1 receptor agonists. In the SURMOUNT-1 trial, participants receiving the 10mg dose achieved an average 19.5% reduction in body weight after 72 weeks of treatment.
As a research compound, tirzepatide 10mg offers scientists valuable insights into dual incretin receptor activation mechanisms. The peptide's unique ability to simultaneously engage both GIP and GLP-1 pathways makes it an important tool for metabolic disorder research.
Our tirzepatide 10mg is supplied as a lyophilized white powder with minimum 99% purity by HPLC analysis. Each vial contains precisely 10mg of active peptide, packaged under sterile conditions to ensure stability and prevent contamination.
This product is intended for research purposes only and is not for human consumption. Proper storage conditions (2-8°C, protected from light and moisture) should be maintained to preserve the integrity of the peptide.
